T1	Participants 103 143	patients on thyroid hormone replacement.
T2	Participants 551 692	697 patients on thyroid hormone replacement therapy at entry to a randomized, controlled trial of combined T(4) and T(3) replacement therapy.
T3	Participants 693 735	All patients were on 100 mug or more T(4).
T4	Participants 1637 1665	treated hypothyroid patients
